Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xianyang
Clinical trial register · China

Clinical Trials in Xianyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Xi'an 120 Yan’an 9 Xianyang 8 Lanzhou 7 Yinchuan 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital8 Hoffmann-La Roche4 Xijing Hospital of Digestive Diseases1 Biocells (Beijing) Biotech Co.,Ltd1 First Affiliated Hospital Xi'an Jiaotong University1 Clear sponsor filter
Site location
Xi'an120 Yan’an9 Xianyang8 Lanzhou7 Yinchuan7
All 38 locations
Target enrolment
to

Trials with a site in Xianyang

8 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
NCT07553754Prostate Cancer (Diagnosis), Bone Metastasis, PSMA PET, Liquid Biopsy
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Weinan, Xi'an, Xianyang, Xining, Yan’an
2026-03-12
Recruiting
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2026-03-03
Recruiting
Xijing Hospital
Observational
3,000
Ankang, Hanzhong, Xi'an, Ya'an, Yunlin, Xianyang, Yan’an
2022-03-01
Recruiting
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086Renal Cancer, Metastases, PSMA PET
Xijing Hospital
Not applicable
300
Lanzhou, Yinchuan, Xining, Xi'an, Weinan, Xianyang, Yan’an
2021-06-01
Recruiting
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
By invitation
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-12
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yan’an
2021-03-05
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/xianyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Xianyang that also match the filters currently applied.

How many clinical trials are recruiting in Xianyang?

7 of the 8 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xianyang), 8 studies
PhaseStudiesRecruitingShare
Observational6675%
Not applicable2125%

Most active sponsors

Lead sponsors with the most studies (Xianyang)
Lead sponsorStudiesRecruiting
Xijing Hospital87
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.